SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-053288
Filing Date
2012-08-01
Accepted
2012-08-01 17:09:47
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-13264_110q.htm 10-Q 891767
2 EX-31.1 a12-13264_1ex31d1.htm EX-31.1 10282
3 EX-31.2 a12-13264_1ex31d2.htm EX-31.2 12877
4 EX-32.1 a12-13264_1ex32d1.htm EX-32.1 5341
5 EX-32.2 a12-13264_1ex32d2.htm EX-32.2 5667
  Complete submission text file 0001104659-12-053288.txt   3306716

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bpax-20120630.xml EX-101.INS 241059
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpax-20120630.xsd EX-101.SCH 32572
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpax-20120630_cal.xml EX-101.CAL 29231
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpax-20120630_def.xml EX-101.DEF 183912
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpax-20120630_lab.xml EX-101.LAB 483947
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpax-20120630_pre.xml EX-101.PRE 239048
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 121000866
SIC: 2836 Biological Products, (No Diagnostic Substances)